Who invested in Dren Bio

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$25Mraised across 1 round since 2024, from 1 source

Latest round: Venture, $25MJul 2024
Investors: 5

See who backed them

The rounds

Jul 2024
Venture$25M
Source recorded

Founders and team

From Dren Bio's own website and the SEC filings it signed: 1 founder, 14 on the team.

Nenad N. TomasevicChief Executive Officer, FounderNamed on its 2022 Form D

Jake RasmussenVice President, Clinical Operations
Jeff MacfarlandExecutive Vice President, Finance
Kevin LeongVice President, Oncology Research
Rachel WarrenVice President, Head of Strategy and Portfolio Management
Shalini GidwaniSenior Vice President, Regulatory Affairs
Sridhar ViswanathanExecutive Vice President, Process Sciences and Manufacturing Operations
Wan-Jen HongSenior Vice President, Head of Oncology Clinical Development
Amit MehtaChief Operating Officer and Chief Business Officer
Alex N. KolicichBoard Director
Andrew N. SchiffBoard Director
Chandra P. LeoBoard Director
Kenneth R LuehrsenIndependent Board Director
Rajeev N. DadooBoard of Directors and Investors
Sakae N. AsanumaBoard Director

Everyone who backed them

8VCVC firm1round

SR OneCorporate VC1round

Alexandria Venture InvestmentsVC firm1round

NovartisVC firm1round

Mission BioCapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 4 firms list Dren Bio as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.